Craneware plc (LON:CRW)‘s stock had its “buy” rating restated by equities researchers at Peel Hunt in a research report issued on Wednesday. They currently have a GBX 1,800 ($23.67) price objective on the stock. Peel Hunt’s target price indicates a potential upside of 20.08% from the stock’s previous close.

Separately, N+1 Singer reissued a “hold” rating on shares of Craneware plc in a research report on Tuesday, September 5th.

Craneware plc (LON CRW) traded down GBX 19 ($0.25) during midday trading on Wednesday, reaching GBX 1,466 ($19.28). 4,054 shares of the company’s stock traded hands, compared to its average volume of 11,784. Craneware plc has a 52 week low of GBX 950 ($12.50) and a 52 week high of GBX 1,885 ($24.79).

COPYRIGHT VIOLATION WARNING: This story was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this story on another publication, it was stolen and republished in violation of U.S. and international copyright & trademark laws. The correct version of this story can be read at https://www.thecerbatgem.com/2017/11/10/craneware-plc-crw-stock-rating-reaffirmed-by-peel-hunt.html.

About Craneware plc

Craneware plc is a United Kingdom-based company, which is engaged in the development, licensing and ongoing support of computer software for the United States healthcare industry. The Company’s Value Cycle Solutions span over five product families, which include Patient Engagement, Charge Capture & Pricing, Coding Integrity, Cost Analytics, and Revenue Collection & Retention.

Receive News & Stock Ratings for Craneware plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Craneware plc and related stocks with our FREE daily email newsletter.